Solu-medrol Injection, Powder, For Solution
Product Images NDC 55154-3944

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Solu-medrol (NDC 55154-3944). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

47507f43 53d3 4e26 85f2 503c2594209c 00

SOLU-MEDROL® is a medication used for injection that contains Methylprednisolone Sodium Succinate. The package consists of 5 sets of 2mL ACT-O-VIAL® SYSTEMS. Each vial contains 125 mg* of Methylprednisolone Sodium Succinate that is meant to be kept at room temperature. The package also contains directions on how to use the ACT-O-VIAL® SYSTEM. The drug is distributed by Pharmacia & Upjohn Co, a division of Pfizer Inc., and the product is intended for institutional use only.*

FDA Label Image

Chemical Structure (Solu Medrol 01)

FDA Label Image

Figure (Solu Medrol 02)

FDA Label Image

Logo (Solu Medrol 03)

G injectables are a type of medication that can be injected into the body. The distributor of these injectables is Praimacia & Upjoh Cc, a division of Pfizer Inc. The company is located in New York, NY 10017.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.